Medications for weight loss
Last updated on May 29, 2024Learning objective
During each academic detailing session, participants will have the opportunity to:
- Apply current evidence to guide prescribing and deprescribing decisions for tirzepatide, semaglutide, liraglutide, naltrexone-bupropion and orlistat
- Compare clinical considerations when choosing between medications
- Discuss dosing, dose response, timing of weight loss effect, effect after stopping, cost
After the academic detailing session, participants will be able to thoughtfully discuss, prescribe, monitor and manage the current, and upcoming, medications for weight loss.
Personalized education in 30-60 minutes via in-person visit or Web conferencing (i.e., Zoom or WebEx) at a time that is convenient for you. This group learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1.0 Mainpro+ credit.
This education session will focus on drug information applicable to adults who may be considering medications that reduce body weight. While important, the following are beyond the scope of these sessions: pediatrics, nutrition, exercise interventions, limitations of body mass index (BMI).
Availability
When: Until February 21, 2025
Where: In-person at your place of work or virtual academic detailing
How: Contact your local PAD pharmacist directly or e-mail PAD@gov.bc.ca
Resources
- Handout - PAD Medications for weight loss (PDF, 878B)
- Drug table - PAD Medications for weight loss (PDF, 312KB)
- References - PAD Medications for weight loss (PDF, 184KB)
For more information about the PAD service, visit About PAD service.